Skip to content

How I Practice: Treatment Landscape for mUC
*Activity Post-Survey & Application for Credit*

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 100% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.
1.What are your specialty & credentials?(Required.)
2.What is your community of practice?
3.What was the most common ≥ grade 3 TRAE associated with enfortumab-vedotin and pembrolizumab in EV-302/ KEYNOTE-A39?(Required.)
4.In JAVELIN Bladder 100 trial, what was the OS rate at 1 year for patients treated with avelumab maintenance therapy?(Required.)
5.A 72-year-old man with mUC is found to have progressive disease on restaging scans 10 months after receiving 1L gemcitabine and cisplatin. Which of the following is the preferred NCCN 2L treatment for this patient?(Required.)
6.In THOR, cohort 1, what was the mPFS for patients treated with erdafitinib?(Required.)
EVALUATION FORM
7.Upon completion of this activity, I am able to:
Strongly agree
Agree
Disagree
Strongly disagree
DESCRIBE efficacy data regarding ICIs and other approved drug classes, including the use of maintenance  therapy in mUC.
SELECT appropriate treatment based on the latest recommendations from the National Comprehensive Cancer  Network’s preferred treatment regimens for mUC.
8.Please indicate the extent of your agreement with the following statements: 
Strongly agree
Agree
Disagree
Strongly disagree
The faculty for this activity were effective
9.Overall, was this activity fair, balanced and free from commercial bias?
10.If no, please explain:
11.Of the patients with bladder cancer you will see in the next month, about how many will benefit from the information you learned today?
12.Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
13.Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
14.For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*(Required.)
15.I certify that I have participated in the continuing education activity entitled, "What Now, What Next? Appropriate Management for mUC | How I Practice: Treatment Landscape for mUC" and claim 0.5 AMA PRA Category 1 CreditTM.(Required.)
Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate.

For additional information about the accreditation of this activity, please visit https://www.partnersed.com
Privacy & Cookie Notice